Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00006994 · ClinicalTrials.gov registry record · Phase 3
S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat
A Phase 3 study, sponsored by SWOG Cancer Research Network.
- Terminated
- Registry status
- Phase 3
- Development phase
- 23
- Enrollment target
NCT00006994 is a Phase 3 study that was terminated before completion, run by SWOG Cancer Research Network. The registered enrollment target is 23 participants.
The verdict
NCT00006994, a Phase 3 study, was terminated before completion, sponsored by SWOG Cancer Research Network.
- TERMINATED
- Registry status
- Phase 3
- Development phase
- 23 participants
- Enrollment target
Study Summary
RATIONALE: Glutamine may be effective in decreasing side effects, such as inflammation of the mouth and throat, caused by radiation therapy. The effectiveness of glutamine for mucositis is not yet known. PURPOSE: Randomized phase III trial to determine the effectiveness of glutamine in treating patients who develop mucositis following radiation therapy for newly diagnosed cancer of the mouth or throat.
Interventions
- RADIATION radiation therapy
- DIETARY_SUPPLEMENT glutamine
- DRUG l-glutamine placebo
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 23 participants |
| Start Date | 2001-11 |
| Est. Completion | 2006-04 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00006994
The ClinicalTrials.gov registry entry for NCT00006994 describes a study currently listed as terminated, categorized as Phase 3. The registered enrollment target is 23 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is SWOG Cancer Research Network, which has 270 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which radiation therapy is the first listed.
NCT00006994 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00006994 about?
NCT00006994 is a clinical study titled "S9908: Glutamine in Treating Mucositis Caused by Radiation Therapy in Patients With Newly Diagnosed Cancer of the Mouth or Throat". RATIONALE: Glutamine may be effective in decreasing side effects, such as inflammation of the mouth and throat, caused by radiation therapy. The effectiveness of glutamine for mucositis is not yet known. PURPOSE: Randomized phase III trial to determine the effectiveness of glutamine in treating pat...
What is the current status of trial NCT00006994?
This trial is currently terminated. It is a Phase 3 study. The enrollment target is 23 participants. The study started on 2001-11. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00006994?
The interventions under investigation include: radiation therapy (RADIATION), glutamine (DIETARY_SUPPLEMENT), l-glutamine placebo (DRUG).
Who is sponsoring clinical trial NCT00006994?
This trial is sponsored by SWOG Cancer Research Network, which has 270 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.